An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2020-10-22
DOI
10.1080/13543776.2021.1841166
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain
- (2020) Austen Lowell Thompson et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Discovery of Aryl Formyl Piperidine Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase Inhibitors
- (2020) Zhuoer Zhi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Classics in Neuroimaging: Imaging the Endocannabinoid Pathway with PET
- (2020) Cassis Varlow et al. ACS Chemical Neuroscience
- The discovery of diazetidinyl diamides as potent and reversible inhibitors of monoacylglycerol lipase (MAGL)
- (2020) Bin Zhu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitors
- (2020) Bin Zhu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor
- (2019) Carlotta Granchi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
- (2019) Giulio Poli et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications
- (2019) Natasha L. Grimsey et al. DRUG DISCOVERY TODAY
- Monoacylglycerol lipase inhibitors: Modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders
- (2019) Hui Deng et al. Acta Pharmaceutica Sinica B
- Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation
- (2018) Laura A. McAllister et al. JOURNAL OF MEDICINAL CHEMISTRY
- Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy
- (2018) Zachary A. Curry et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington’s disease
- (2018) Dan P. Covey et al. NEUROPSYCHOPHARMACOLOGY
- Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors
- (2018) Giulia Bononi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders
- (2018) Justin S. Cisar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis, and evaluation of piperazinyl pyrrolidin-2-ones as a novel series of reversible monoacylglycerol lipase inhibitors
- (2018) Jumpei Aida et al. JOURNAL OF MEDICINAL CHEMISTRY
- Monoacylglycerol Lipase Inhibition in Human and Rodent Systems Supports Clinical Evaluation of Endocannabinoid Modulators
- (2018) Jason R. Clapper et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017)
- (2017) Carlotta Granchi et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS
- (2017) Noemi Pasquarelli et al. NEUROPHARMACOLOGY
- Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors
- (2016) Carlotta Granchi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of Monoacylglycerol Lipase Activity Decreases Glucose-Stimulated Insulin Secretion in INS-1 (832/13) Cells and Rat Islets
- (2016) Charles A. Berdan et al. PLoS One
- Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice
- (2015) Molly S Crowe et al. BRITISH JOURNAL OF PHARMACOLOGY
- Designing Irreversible Inhibitors-Worth the Effort?
- (2015) Concepción González-Bello ChemMedChem
- Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase
- (2015) Dina Navia-Paldanius et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
- (2015) Ross B. Mounsey et al. EXPERIMENTAL NEUROLOGY
- 4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors
- (2015) Carlotta Granchi et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesity
- (2015) John D. Douglass et al. JOURNAL OF LIPID RESEARCH
- Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB1R signaling and anxiety-like behavior
- (2015) Roberta Imperatore et al. JOURNAL OF NEUROCHEMISTRY
- Endocannabinoid signalling and the deteriorating brain
- (2015) Vincenzo Di Marzo et al. NATURE REVIEWS NEUROSCIENCE
- A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis
- (2014) Gloria Hernández-Torres et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Identification and characterization of a new reversible MAGL inhibitor
- (2014) Tiziano Tuccinardi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The Role of Monoacylglycerol Lipase (MAGL) in the Cancer Progress
- (2014) Hong Qin et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Radiosynthesis and ex vivo evaluation of [11C-carbonyl]carbamate- and urea-based monoacylglycerol lipase inhibitors
- (2014) Justin W. Hicks et al. NUCLEAR MEDICINE AND BIOLOGY
- Proteome-Wide Reactivity Profiling Identifies Diverse Carbamate Chemotypes Tuned for Serine Hydrolase Inhibition
- (2013) Jae Won Chang et al. ACS Chemical Biology
- Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy
- (2013) Mireille Alhouayek et al. DRUG DISCOVERY TODAY
- Quantum Mechanics/Molecular Mechanics Modeling of Fatty Acid Amide Hydrolase Reactivation Distinguishes Substrate from Irreversible Covalent Inhibitors
- (2013) Alessio Lodola et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic potential of monoacylglycerol lipase inhibitors
- (2012) Melinda M. Mulvihill et al. LIFE SCIENCES
- Monoacylglycerol Lipase Is a Therapeutic Target for Alzheimer's Disease
- (2012) Rongqing Chen et al. Cell Reports
- O-Hydroxyacetamide Carbamates as a Highly Potent and Selective Class of Endocannabinoid Hydrolase Inhibitors
- (2011) Micah J. Niphakis et al. ACS Chemical Neuroscience
- The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors
- (2011) J. R. Savinainen et al. Acta Physiologica
- Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: A comprehensive review from an analytical and biological perspective
- (2011) Alexander A. Zoerner et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Monoglyceride Lipase Deficiency in Mice Impairs Lipolysis and Attenuates Diet-induced Insulin Resistance
- (2011) Ulrike Taschler et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
- (2011) D. K. Nomura et al. SCIENCE
- A Review on the Monoacylglycerol Lipase: At the Interface Between Fat and Endocannabinoid Signalling
- (2010) G. Labar et al. CURRENT MEDICINAL CHEMISTRY
- Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system
- (2010) Joel E Schlosburg et al. NATURE NEUROSCIENCE
- A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors
- (2009) AR King et al. BRITISH JOURNAL OF PHARMACOLOGY
- Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis
- (2009) Daniel K. Nomura et al. CELL
- Crystal Structure of the Human Monoacylglycerol Lipase, a Key Actor in Endocannabinoid Signaling
- (2009) Geoffray Labar et al. CHEMBIOCHEM
- Structural Basis for Human Monoglyceride Lipase Inhibition
- (2009) T. Bertrand et al. JOURNAL OF MOLECULAR BIOLOGY
- Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain
- (2009) S. G. Kinsey et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo
- (2009) J. Z. Long et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CAY10499, a Novel Monoglyceride Lipase Inhibitor Evidenced by an Expeditious MGL Assay
- (2008) Giulio G. Muccioli et al. CHEMBIOCHEM
- Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
- (2008) Jonathan Z Long et al. Nature Chemical Biology
- Cannabinoid pharmacology: the first 66 years
- (2006) Roger G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started